CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 19, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Frederick Locke, MD, Program Co-Leader, Immunology, Moffitt Cancer Center discuss CAR-T clinical highlights from ASH 2018

Featured Videos

Parameswaran Hari, MD, elaborates on the outcome from the ECOG trial in SMM

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents

Sandip Patel, MD, speculates on the impact of the RELAY trial presented at ASCO 2019